Product Information
YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR is a brand biologic product labeled by CELLTRION USA, Inc., priced at $913.5967 per EA under NDC 72606003009. Its NADAC has been published 27 times since Feb 18, 2026.
Manufacturer
CELLTRION USA, Inc.NDC
72606003009
Classification
Brand Biologic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Biologic (BLA)
FDA Application
BLA761219On Market Since
5/23/2023
Price Statistics
The NADAC for YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR has been published 27 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $913.5967 per EA |
|---|---|
| All-time high | $913.5967 (Aug 19, 2026) |
| All-time low | $912.3800 (Feb 18, 2026) |
| 52-week high | $913.5967 |
| 52-week low | $912.3800 |
| Median price | $913.5967 |
| Average price | $913.4164 |
| Largest weekly change | +0.1% (Mar 18, 2026) |
| Weeks tracked | 27 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR, manufactured by CELLTRION USA, Inc., is $913.5967 per EA (NDC 72606003009), effective Aug 19, 2026.
How has the price of YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR changed over time?
Over the history we have for it, the NADAC for YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR has held within roughly two percent of its current level. It has been tracked across 27 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR?
Since Feb 18, 2026, the NADAC for YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR has ranged from a low of $912.3800 (Feb 18, 2026) to a high of $913.5967 (Aug 19, 2026), with a median of $913.5967 per EA.
Are there cheaper alternatives to YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR, is $492.1422 per EA — about 46% below YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR.
Who manufactures YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR?
YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR (NDC 72606003009) is labeled by CELLTRION USA, Inc., and CMS classifies it as a brand biologic product.